Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery

被引:0
|
作者
Li, Qingxin [1 ]
Kang, Congbao [2 ]
机构
[1] Guangdong Acad Sci, Inst Biol & Med Engn, Guangdong Prov Engn Lab Biomass High Value Utiliza, Guangzhou 510316, Peoples R China
[2] ASTAR, Expt Drug Dev Ctr EDDC, 10 Biopolis Rd,05-01, Singapore 138670, Singapore
来源
MOLECULES | 2024年 / 29卷 / 23期
关键词
F-19-NMR; fragment screening; drug discovery; fragment-based drug design; in-cell F-19-NMR; OBSERVED FLUORINE NMR; PROTEIN-PROTEIN INTERACTIONS; LIGAND BINDING; STD NMR; RNA; SPECTROSCOPY; IDENTIFICATION; TOOL; QUANTIFICATION; VALIDATION;
D O I
10.3390/molecules29235748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based drug discovery is a powerful approach in drug discovery, applicable to a wide range of targets. This method enables the discovery of potent compounds that can modulate target functions, starting from fragment compounds that bind weakly to the targets. While biochemical, biophysical, and cell-based assays are commonly used to identify fragments, F-19-NMR spectroscopy has emerged as a powerful tool for exploring interactions between biomolecules and ligands. Because fluorine atoms are not naturally present in biological systems, F-19-NMR serves as a sensitive method for fragment screening against diverse targets. Herein, we reviewed the applications of F-19-NMR in fragment screening, highlighting its effectiveness in identifying fragments that bind weakly to various targets such as proteins and RNA. The accumulated evidence suggests that F-19-NMR will continue to be a crucial tool in drug discovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Applications of 19F-NMR in Fragment-Based Drug Discovery
    Norton, Raymond S.
    Leung, Eleanor W. W.
    Chandrashekaran, Indu R.
    MacRaild, Christopher A.
    MOLECULES, 2016, 21 (07)
  • [2] 19F-NMR in Target-based Drug Discovery
    Kang, CongBao
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (26) : 4964 - 4983
  • [3] NMR Screening in the Fragment-based Drug Discovery
    Hanzawa, Hiroyuki
    Takizawa, Takeshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (03): : 325 - 333
  • [4] Fragment-based drug discovery using NMR spectroscopy
    Mary J. Harner
    Andreas O. Frank
    Stephen W. Fesik
    Journal of Biomolecular NMR, 2013, 56 : 65 - 75
  • [5] Fragment-based drug discovery using NMR spectroscopy
    Harner, Mary J.
    Frank, Andreas O.
    Fesik, Stephen W.
    JOURNAL OF BIOMOLECULAR NMR, 2013, 56 (02) : 65 - 75
  • [6] Fragment-based drug discovery
    Erlanson, DA
    McDowell, RS
    O'Brien, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) : 3463 - 3482
  • [7] Fragment-based drug discovery
    Wendy A. Warr
    Journal of Computer-Aided Molecular Design, 2009, 23 : 453 - 458
  • [8] Fragment-based drug discovery
    Warr, Wendy A.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (08) : 453 - 458
  • [9] Fragment-Based Drug Discovery
    Norton, Raymond S.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (12) : 1463 - 1464
  • [10] 19F NMR viewed through two different lenses: ligand-observed and protein-observed 19F NMR applications for fragment-based drug discovery
    Buchholz, Caroline R.
    Pomerantz, William C. K.
    RSC CHEMICAL BIOLOGY, 2021, 2 (05): : 1312 - 1330